Absolving COVID-19 Vaccination of Autoimmune Bullous Disease Onset

Front Immunol. 2022 Feb 18:13:834316. doi: 10.3389/fimmu.2022.834316. eCollection 2022.

Authors

Roberto Russo^{1

2}, Giulia Gasparini^{1

2}, Emanuele Cozzani^{1

2}, Federica D'Agostino^{1

2}, Aurora Parodi^{1

2}

Affiliations

¹ Dipartimento di Scienze della Salute (DISSAL), Section of Dermatology, University of Genoa, Genoa, Italy.
² Department of Dermatology, San Martino Polyclinic Hospital, Genoa, Italy.

No abstract available

Keywords: COVID-19; autoimmune bullous diseases; bullous pemphigoid; pemphigus vulgaris; vaccines.

Publication types

Case Reports

MeSH terms

Aged
Autoimmune Diseases / immunology*
COVID-19 / immunology*
COVID-19 Vaccines / immunology*
Humans
Male
Pemphigoid, Bullous / immunology*
Vaccination / methods

Substances

COVID-19 Vaccines